Buying or selling a cannabis business in Louisiana

Is cannabis legal in Louisiana?

For patients with a physician recommendation, yes. Adult-use sales are not legal. The governing statute is La. R.S. 40:1046, which calls the product “marijuana for therapeutic use”. Regulation was split for years between the Department of Agriculture and Forestry for production and the Board of Pharmacy for dispensing. Act 693 of 2024 consolidated retail oversight in the Louisiana Department of Health from 1 January 2025, and LDH adopted implementing rules published in the Louisiana Register in January 2026, creating a “marijuana retailer” permit in place of the old marijuana pharmacy licence.

That handover matters to a buyer. Any target whose diligence file predates 2025 was permitted under a different agency with different rules, and conversion paperwork is a real diligence item.

What licences exist, and how many?

Two tiers, both tightly capped, and neither structured like a normal cannabis market.

Tier	Cap	How it was awarded	Published fees
Production licence	No more than 2	To contractors of the LSU and Southern University agricultural centers, effective 1 July 2024	$10,000 application, $100,000 a year, plus 7 percent of gross sales
Marijuana retailer	10 regional permits, up to 30 locations	One per LDH administrative region, plus satellites	$22,500 a year per permit holder

Fee and cap figures come from La. R.S. 40:1046. A retail permit holder may open a satellite location once it serves 3,500 patients and a second at 7,000 patients, with a statewide ceiling of 30 locations. Around 23 were operating in 2026, so some authorised expansion capacity is still unused, which is one of the few organic growth levers in the state.

Louisiana is therefore a limited-licence state with an unusual twist: the production tier is not merely capped, it is contractually bound to two public university agricultural centers, so no third producer can be created without the legislature.

How does a sale work in Louisiana?

Retail changes hands at the equity level. The statute provides that transfer of a membership interest in an entity that holds a marijuana retail permit may be conducted without approval of the department. That is unusual: in most states an ownership change is the regulator’s trigger event, as described in change of ownership approval. It does not mean nothing is required. The permit is tied to the entity and the location, the underlying owners and key personnel still have to satisfy LDH’s suitability rules, and the department’s 2026 rules govern what has to be reported and when. Treat the statutory language as removing an approval condition precedent, not as removing regulatory diligence, and confirm current practice with LDH before relying on it in a purchase agreement.

Production is different again. With only two licences, both anchored in university contracts, a change of control is a negotiation involving the university partner as well as the state. Anyone modelling that should read true-party-of-interest and financial-interest rules and expect the contract, not just the licence, to drive the deal.

The statute also contains a political-contribution restriction on production bidders and their controlling persons, which is a real disqualifier to check in diligence.

Taxes, 280E and track-and-trace

Louisiana’s biggest cannabis-specific cost sits on the producer: 7 percent of gross sales, on top of the $100,000 annual licence fee. Retail permit holders pay $22,500 a year. Louisiana has not enacted a 280E decoupling statute, which matters less than it once did. Because every Louisiana licensee is a state-licensed medical operator, the April 2026 Schedule III order puts qualifying activity outside 280E going forward with nothing to apportion, and state conformity carries the deductions through to the Louisiana return. That change is worth more to a Louisiana operator than to a dual operator in an adult-use state. Louisiana reports through Metrc; see track-and-trace systems and transactions.

Market conditions

Louisiana does not publish a public monthly sales dashboard comparable to Michigan’s or Oregon’s, so underwrite from the target’s own point-of-sale and Metrc data rather than from state aggregates. The structural picture is clear enough: a state of about 4.6 million people, two producers supplying every product sold, and fewer than 30 permitted storefronts. Concentrated supply means a retailer’s margin depends heavily on two wholesale relationships, and a supply interruption at either producer is a genuine single-point-of-failure risk that belongs in the due diligence checklist.

What this means for sellers and buyers

Sellers. A Louisiana retail position is scarce, has some unused satellite capacity attached, and sits in a programme whose federal tax treatment improved in April 2026. The statutory freedom to transfer membership interests without a department approval condition shortens the timetable relative to most states, which is a genuine selling point when negotiating a cannabis sale timeline.

Buyers. Diligence the conversion from Board of Pharmacy licence to LDH retailer permit, the patient counts that support any satellite rights, and the wholesale terms with the two producers. Do not assume a production licence is purchasable. Confirm every fee and filing requirement with LDH, because the rules changed in 2025 and again in 2026. This page is educational, not legal or tax advice.